Prenatal programming of renal salt wasting resets postnatal salt appetite, which drives food intake in the rat

2012 ◽  
Vol 122 (10) ◽  
pp. 485-485 ◽  
Author(s):  
S. H. Alwasel ◽  
D. J. P. Barker ◽  
N. Ashton
2011 ◽  
Vol 122 (6) ◽  
pp. 281-288 ◽  
Author(s):  
Saleh H. Alwasel ◽  
David J. P. Barker ◽  
Nick Ashton

Sodium retention has been proposed as the cause of hypertension in the LP rat (offspring exposed to a maternal low-protein diet in utero) model of developmental programming because of increased renal NKCC2 (Na+/K+/2Cl− co-transporter 2) expression. However, we have shown that LP rats excrete more rather than less sodium than controls, leading us to hypothesize that LP rats ingest more salt in order to maintain sodium balance. Rats were fed on either a 9% (low) or 18% (control) protein diet during pregnancy; male and female offspring were studied at 4 weeks of age. LP rats of both sexes held in metabolism cages excreted more sodium and urine than controls. When given water to drink, LP rats drank more and ate more food than controls, hence sodium intake matched excretion. However, when given a choice between saline and water to drink, the total volume of fluid ingested by LP rats fell to control levels, but the volume of saline taken was significantly larger [3.8±0.1 compared with 8.8±1.3 ml/24 h per 100 g of body weight in control and LP rats respectively; P<0.001]. Interestingly food intake also fell to control levels. Total body sodium content and ECF (extracellular fluid) volumes were greater in LP rats. These results show that prenatal programming of renal sodium wasting leads to a compensatory increase in salt appetite in LP rats. We speculate that the need to maintain salt homoeostasis following malnutrition in utero stimulates greater food intake, leading to accelerated growth and raised BP (blood pressure).


Author(s):  
John K. Maesaka ◽  
Louis J. Imbriano ◽  
Aaron Pinkhasov ◽  
Rajanandini Muralidharan ◽  
Xiaomin Song ◽  
...  

Author(s):  
Branislav Lichardus ◽  
Endre Sulyok ◽  
L�szl� Kov�cs ◽  
Nikolaj Michajlovskij ◽  
Veronika Lehotsk� ◽  
...  

2009 ◽  
Vol 76 (9) ◽  
pp. 934-938 ◽  
Author(s):  
John K. Maesaka ◽  
Louis J. Imbriano ◽  
Nicole M. Ali ◽  
Ekambaram Ilamathi

2017 ◽  
Vol 2017 ◽  
pp. 1-4
Author(s):  
Phuong-Chi Pham ◽  
Pavani Reddy ◽  
Shaker Qaqish ◽  
Ashvin Kamath ◽  
Johana Rodriguez ◽  
...  

Cisplatin is known to induce Fanconi syndrome and renal salt wasting (RSW). RSW typically only requires transient normal saline (NS) support. We report a severe RSW case that required 12 liters of 3% saline. A 57-year-old woman with limited stage small cell cancer was admitted for cisplatin (80 mg/m2) and etoposide (100 mg/m2) therapy. Patient’s serum sodium (SNa) decreased from 138 to 133 and 125 mEq/L within 24 and 48 hours of cisplatin therapy, respectively. A diagnosis of syndrome of inappropriate antidiuretic hormone secretion (SIADH) was initially made. Despite free water restriction, patient’s SNa continued to decrease in association with acute onset of headaches, nausea, and dizziness. Three percent saline (3%S) infusion with rates up to 1400 mL/day was required to correct and maintain SNa at 135 mEq/L. Studies to evaluate Fanconi syndrome revealed hypophosphatemia and glucosuria in the absence of serum hyperglycemia. The natriuresis slowed down by 2.5 weeks, but 3%S support was continued for a total volume of 12 liters over 3.5 weeks. Attempts of questionable benefits to slow down glomerular filtration included the administration of ibuprofen and benazepril. To our knowledge, this is the most severe case of RSW ever reported with cisplatin.


2014 ◽  
Vol 3 (4) ◽  
pp. 1373-1385 ◽  
Author(s):  
John Maesaka ◽  
Louis Imbriano ◽  
Joseph Mattana ◽  
Dympna Gallagher ◽  
Naveen Bade ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document